Opiant Pharmaceuticals, Inc.

CIK 1385508 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Opiant Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jul 11, 2023CT ORDER9999999997-23-003513
Mar 13, 202315-12G0001193125-23-068421
Mar 9, 2023EFFECT9999999995-23-000550
Mar 9, 2023EFFECT9999999995-23-000553
Mar 9, 2023EFFECT9999999995-23-000551
Mar 6, 2023S-8 POS0001385508-23-000083
Mar 6, 2023S-8 POS0001385508-23-000087
Mar 6, 2023S-8 POS0001385508-23-000085
Mar 6, 2023S-8 POS0001385508-23-000081
Mar 6, 2023S-8 POS0001385508-23-000089
Mar 6, 2023POS AM0001385508-23-000091
Mar 6, 2023POS AM0001385508-23-000093
Mar 6, 2023POS AM0001385508-23-000095
Mar 6, 2023S-8 POS0001385508-23-000079
Mar 3, 202340001385508-23-000077
Mar 3, 202340001385508-23-000063
Mar 3, 202340001385508-23-000065
Mar 3, 202340001385508-23-000057
Mar 3, 202340001385508-23-000067
Mar 3, 202340001385508-23-000071
Mar 3, 202340001385508-23-000059
Mar 3, 202340001385508-23-000069
Mar 3, 202340001385508-23-000053
Mar 3, 202340001385508-23-000061
Mar 3, 202340001385508-23-000075